Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Jennifer Kwak

Concepts (155)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Fluorodeoxyglucose F18
10
2023
113
1.490
Why?
Positron-Emission Tomography
12
2023
259
1.480
Why?
Sentinel Lymph Node
5
2019
37
1.220
Why?
Sentinel Lymph Node Biopsy
6
2019
99
1.160
Why?
Melanoma
8
2019
620
1.080
Why?
Head and Neck Neoplasms
5
2019
427
0.920
Why?
Multimodal Imaging
6
2016
88
0.870
Why?
Skin Neoplasms
6
2019
756
0.850
Why?
Fever of Unknown Origin
1
2023
7
0.850
Why?
Single Photon Emission Computed Tomography Computed Tomography
2
2019
10
0.830
Why?
Thyroid Neoplasms
3
2020
264
0.780
Why?
Radiopharmaceuticals
10
2023
157
0.770
Why?
Lymphoscintigraphy
2
2019
9
0.720
Why?
Graves Disease
1
2020
32
0.710
Why?
Spirituality
1
2020
69
0.650
Why?
Lung Neoplasms
8
2023
2177
0.580
Why?
Positron Emission Tomography Computed Tomography
5
2023
63
0.580
Why?
Chemoradiotherapy, Adjuvant
2
2016
40
0.560
Why?
Iodine Radioisotopes
4
2020
125
0.510
Why?
Tomography, X-Ray Computed
7
2016
2286
0.500
Why?
Rectal Neoplasms
1
2016
121
0.490
Why?
Hamartoma
1
2015
20
0.480
Why?
Four-Dimensional Computed Tomography
4
2021
25
0.430
Why?
Diagnostic Imaging
1
2015
275
0.410
Why?
Immunotherapy
1
2015
474
0.370
Why?
Neoplasm Recurrence, Local
4
2020
859
0.370
Why?
Radiation Pneumonitis
2
2021
24
0.350
Why?
Adenocarcinoma
1
2016
795
0.340
Why?
Lung
5
2023
3561
0.330
Why?
Neuroendocrine Tumors
2
2022
85
0.300
Why?
Chemoradiotherapy
2
2020
188
0.300
Why?
Lymph Node Excision
2
2019
139
0.290
Why?
Respiratory-Gated Imaging Techniques
2
2016
10
0.260
Why?
Tomography, Emission-Computed, Single-Photon
4
2023
76
0.250
Why?
Humans
33
2023
114709
0.230
Why?
Radiotherapy Planning, Computer-Assisted
3
2021
117
0.230
Why?
Esophageal Neoplasms
2
2018
273
0.220
Why?
Lymphatic Metastasis
3
2019
275
0.220
Why?
Retrospective Studies
10
2022
12556
0.210
Why?
Aged
13
2022
19074
0.200
Why?
Neoplasms
1
2015
2097
0.190
Why?
Radioisotopes
2
2022
28
0.190
Why?
Methimazole
1
2020
6
0.180
Why?
Antithyroid Agents
1
2020
11
0.180
Why?
Middle Aged
14
2020
26738
0.180
Why?
Aged, 80 and over
8
2020
6347
0.170
Why?
Image-Guided Biopsy
1
2019
31
0.170
Why?
Nuclear Medicine
1
2019
7
0.170
Why?
Religion
1
2020
64
0.170
Why?
Treatment Failure
1
2020
331
0.170
Why?
Scalp
1
2019
29
0.170
Why?
Radionuclide Imaging
1
2019
115
0.160
Why?
Male
18
2020
55609
0.160
Why?
Thyroid Gland
1
2019
82
0.160
Why?
Prognosis
5
2019
3330
0.160
Why?
Skin Pigmentation
1
2019
39
0.160
Why?
ROC Curve
2
2018
442
0.150
Why?
Lymphoma, Mantle-Cell
1
2018
18
0.150
Why?
Attitude
1
2020
229
0.150
Why?
Radiotherapy
1
2018
176
0.150
Why?
Radiotherapy, Intensity-Modulated
1
2018
124
0.140
Why?
Image Interpretation, Computer-Assisted
2
2016
223
0.140
Why?
Neoadjuvant Therapy
2
2016
304
0.140
Why?
Lymph Nodes
1
2019
419
0.140
Why?
Tretinoin
1
2018
122
0.140
Why?
Mediastinal Neoplasms
1
2017
33
0.140
Why?
Bone Marrow
1
2018
244
0.140
Why?
Female
17
2020
59523
0.140
Why?
Lung Diseases
1
2023
701
0.130
Why?
Software Validation
1
2016
7
0.130
Why?
Lymphoma
1
2017
177
0.130
Why?
Solitary Pulmonary Nodule
1
2016
21
0.130
Why?
Pulmonary Ventilation
3
2021
72
0.130
Why?
Societies, Medical
1
2019
664
0.130
Why?
Dacarbazine
1
2015
99
0.130
Why?
MAP Kinase Kinase Kinases
1
2016
68
0.130
Why?
Programmed Cell Death 1 Receptor
1
2017
194
0.130
Why?
Area Under Curve
1
2016
274
0.120
Why?
Disease-Free Survival
4
2019
620
0.120
Why?
Octreotide
1
2015
26
0.120
Why?
Phenylurea Compounds
1
2015
82
0.120
Why?
Adult
9
2020
30554
0.120
Why?
Quinolines
1
2015
129
0.120
Why?
Carcinoma, Papillary, Follicular
1
2014
8
0.120
Why?
Glycolysis
1
2016
227
0.120
Why?
Organometallic Compounds
1
2015
98
0.120
Why?
Carcinoma, Non-Small-Cell Lung
1
2022
961
0.110
Why?
Proto-Oncogene Proteins B-raf
1
2016
192
0.110
Why?
Kaplan-Meier Estimate
1
2016
811
0.110
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2016
1356
0.110
Why?
Treatment Outcome
3
2016
9088
0.110
Why?
Case-Control Studies
1
2020
3004
0.110
Why?
Antibodies, Monoclonal, Humanized
1
2017
663
0.100
Why?
Survival Rate
4
2019
1644
0.100
Why?
Carcinoma
1
2014
198
0.100
Why?
Inflammation
1
2023
2480
0.100
Why?
Imaging, Three-Dimensional
1
2016
512
0.100
Why?
Bone and Bones
1
2015
279
0.100
Why?
Practice Guidelines as Topic
1
2019
1395
0.100
Why?
Sensitivity and Specificity
1
2016
1694
0.100
Why?
Perfusion
2
2023
148
0.100
Why?
Antibodies, Monoclonal
1
2017
1264
0.090
Why?
Carcinoma, Squamous Cell
1
2016
577
0.090
Why?
Prostatic Neoplasms
1
2015
921
0.080
Why?
Prospective Studies
4
2023
6220
0.080
Why?
Postoperative Complications
1
2019
2128
0.080
Why?
United States
2
2022
12186
0.070
Why?
Antineoplastic Agents
1
2017
1879
0.070
Why?
Brain Neoplasms
1
2014
979
0.070
Why?
Whole Body Imaging
2
2018
19
0.070
Why?
Follow-Up Studies
3
2019
4411
0.060
Why?
Magnetic Resonance Imaging
1
2015
3053
0.060
Why?
Child
1
2023
18422
0.060
Why?
Receptors, Somatostatin
1
2022
24
0.050
Why?
Respiration
1
2023
180
0.050
Why?
Ligands
1
2022
562
0.040
Why?
Pulmonary Atelectasis
1
2018
11
0.040
Why?
Europe
1
2019
334
0.040
Why?
Biological Transport
1
2019
374
0.040
Why?
Thyroglobulin
1
2018
17
0.040
Why?
Radiotherapy Dosage
1
2018
244
0.040
Why?
Observer Variation
1
2018
296
0.040
Why?
Medicare
1
2022
665
0.040
Why?
Occipital Bone
1
2017
17
0.030
Why?
Parotid Gland
1
2017
24
0.030
Why?
Respiratory Function Tests
1
2018
522
0.030
Why?
Axilla
1
2017
39
0.030
Why?
Survival Analysis
1
2020
1211
0.030
Why?
Neck
1
2017
85
0.030
Why?
Radiology
1
2018
141
0.030
Why?
Response Evaluation Criteria in Solid Tumors
1
2016
13
0.030
Why?
Heart
1
2020
612
0.030
Why?
Maximum Tolerated Dose
1
2015
183
0.030
Why?
Fluorouracil
1
2016
152
0.030
Why?
Tumor Burden
1
2016
259
0.030
Why?
Myocardium
1
2020
913
0.030
Why?
Cisplatin
1
2016
262
0.030
Why?
Recurrence
1
2017
935
0.030
Why?
Computer Simulation
1
2018
873
0.030
Why?
Adolescent
3
2018
17855
0.030
Why?
Carcinoma, Papillary
1
2014
73
0.030
Why?
Neoplasm Metastasis
1
2016
523
0.030
Why?
Preoperative Care
1
2016
319
0.030
Why?
Analysis of Variance
1
2016
1226
0.030
Why?
Research Design
1
2018
928
0.030
Why?
Ultrasonography
1
2015
634
0.030
Why?
Biopsy
1
2015
1036
0.020
Why?
Young Adult
2
2018
10472
0.020
Why?
Dose-Response Relationship, Drug
1
2015
1842
0.020
Why?
Reproducibility of Results
1
2018
2765
0.020
Why?
Predictive Value of Tests
1
2016
1796
0.020
Why?
Protein Kinase Inhibitors
1
2016
785
0.020
Why?
Algorithms
1
2016
1470
0.020
Why?
Cohort Studies
1
2018
4895
0.020
Why?
Mutation
1
2016
3346
0.020
Why?
Kwak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)